Page History
Approach 3: taking a similar approach as SEND in MI domain modeling where MI test = microscopic examination, the identified abnormality is the result and the location of said abnormality is mapped to RESLOC.
Dataset wrap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Pros: |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cons: |
| |||||||||
Vote: |
|
Approach 1: using result location variables
...
Pros: |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cons: |
| |||||||||
Vote: |
|
Approach 3: taking a similar approach as SEND in MI domain modeling where MI test = microscopic examination, the identified abnormality is the result and the location of the said abnormality is mapped to RESLOC.
...
title | cv.xpt |
---|---|
Name | TU |
...
hi1style | yellow |
---|---|
hi2 | 7 |
hi1 | 6 |
hi2style | aqua |
tableid | TU1 |
...
Row
...
STUDYID
...
DOMAIN
...
USUBJID
...
TUSEQ
...
TUTEST
...
TULOC
...
TUORRES
...
TUMETHOD
...
VISITNUM
...
VISIT
...
TUDTC
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
TUDY01
...
- Reusibility of the result location variables in other domains.
- Simplicity: there is only one location for TULOC for the Lesion Location Identification process. Imaging location is treated as the general location for TULOC, and all result locations are under the RESLOC variable.
- We can represent the different types of lesions in TUORRES, i.e. aneurysm, calcified- annulus or -valvular leaflets, stenosis, or an actual lesion in TUORRES, thusly avoiding the creation of lesion-type specific TUTESTs.
- Because we are dealing with a "lesion (TU) domain", the TUTEST= Lesion Indicator, is created as a "general question" that would allow users to create a record on whether or not a lesion is present in a region. As mentioned in bullet point 2, a lesion can be an aneurysm, calcified annulus or valvular leaflets, stenosis and so on - so TUTEST = Lesion Indicator is all encompassing. This question also allows users to create a negative record when the lesion is no longer identifiable after treatments.
- We all like this better yay win~
- We currently have DIR, LAT, PORTOT, Loc Detail, how many more LOC-related variables might we need if there are more locations info that we need to represent. For example, the graft use-case where we need to indicate that a location is a graft, or transplant, we created a NSV for that.
Overview
Content Tools